Home›People›Conor Cullinane
Conor Cullinane

Conor Cullinane

Co‑Founder, Chairman, CEO, President, Principal Investigator at Pirouette Pharma.

ExecutiveDirector
Updated Nov 10, 2026·Latest SEC filing Mar 18, 2026·Suggest an edit

About Conor Cullinane

Conor Cullinane is a co‑founder, chairman, CEO, president, principal investigator at Pirouette Pharma.

Conor Cullinane first appears on SEC filings in 2021.

Experience

This experience comes from Conor Cullinane's profile and from SEC filings. For roles taken from filings, the years are when the filings name Conor Cullinane in the role, so the role may have started earlier or lasted longer.

Pirouette Pharma Inc. Current
Co‑Founder, Chairman, CEO, President, Principal Investigator
President & CEO, Co-Founder (2017 – Present)
2017 – Present · Portsmouth, NH
Develops automatic injectors for patients who need injectable medicines at home.
NASA - National Aeronautics and Space Administration
NASA Space Technology Research Fellow
2014 – 2018
Harvard Medical School & Massachusetts Institute of Technology
PHD Candidate
2013 – 2018
Commemorative Air Force
Flight Engineer
2014 – 2016
Massachusetts General Hospital
Radiation Oncology Research Assistant
2013 – 2014
roCKeT Division
Co-Founder, Lead Design Engineer
2012 – 2013
Clarkson University
Research Assistant
2011 – 2013

Key Colleagues at Startups

The people Conor Cullinane works with at each company, as listed on that company's latest Form D.

Pirouette Pharma Inc. · Form D, Mar 18, 2026
JN
Matthew Kane
Matthew Kane
Co-Founder, Secretary, and Chief Operating Officer, director
Elijah Kapas
Elijah Kapas
Co-Founder and Chief Technology Officer

Sources

  1. SECPirouette Pharma Inc. Form D, filed Mar 18, 2026